Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Amazon Among Bidders for Signify Health

Amazon Among Bidders for Signify Health

-Wall Street Journal https://www.wsj.com/articles/amazon-among-bidders-for-signify-health-11661123042

byCharles Gross

August 21, 2022

1 minute read

-Wall Street Journal

https://www.wsj.com/articles/amazon-among-bidders-for-signify-health-11661123042

Piper Sandler Maintains Overweight on IBEX Holdings, Raises Price Target to $21

By Benzinga Newsdesk

July 18, 6:49 AM

Piper Sandler analyst Arvind Ramnani maintains IBEX Holdings (NASDAQ:IBEX) with a Overweight and raises the price target from $17 to $21.

IBEX

Fulcrum Therapeutics To Rally Around 120%? FDA Update Removes Overhang On Pivotal Program

By Vandana Singh

August 23, 2:31 PM

Tuesday, the FDA lifted the clinical hold on Fulcrum Therapeutics Inc's (NASDAQ: FULC) Investigational New Drug (IND) application for FTX-6058 for the potential treatment of

FULC

Novartis Agrees To Acquire German Blood Cancer-Drug Developer MorphoSys For €2.7B

By Vandana Singh

February 6, 9:46 AM

Novartis' €2.7 billion public takeover offer for MorphoSys, unlocking a promising oncology pipeline with pelabresib and tulmimetostat.

INCY

Maximus Sees FY24 EPS $5.05-$5.35 Vs $4.16 Est.; Revenue $5.05B-$5.20B Vs $5.18B Est.

By Benzinga Newsdesk

November 15, 5:18 PM

Fiscal Year 2024 Outlook

MAXN

Amazon Among Bidders for Signify Health

Related Posts

Piper Sandler Maintains Overweight on IBEX Holdings, Raises Price Target to $21

Fulcrum Therapeutics To Rally Around 120%? FDA Update Removes Overhang On Pivotal Program

Novartis Agrees To Acquire German Blood Cancer-Drug Developer MorphoSys For €2.7B

Maximus Sees FY24 EPS $5.05-$5.35 Vs $4.16 Est.; Revenue $5.05B-$5.20B Vs $5.18B Est.